The outcomes and treatment strategies in metastatic soft tissue sarcoma treated with immunotherapy-based therapy: a three-center study
The immunotherapy-based therapy showed promising activity in survival, especially in certain histological subtypes (undifferentiated pleomorphic sarcoma, dedifferentiated liposarcoma, myxofibrosarcoma, and angiosarcoma), as well as in combination treatment and in early lines. Prospective researches are needed to confirm the potential benefits.
Authors
- Weitao Yao (ORCID: https://orcid.org/0000-0002-0336-6249)
- Jiaqiang Wang (ORCID: https://orcid.org/0000-0002-4978-1501)
- Zhiyong Liu
- Xin Wang (ORCID: https://orcid.org/0000-0002-0333-0238)
- Peng Zhang (ORCID: https://orcid.org/0000-0003-1618-9728)
- Kang Cui
- Songtao Gao
Institutions
- Zhengzhou University (CN)
- Henan Provincial People's Hospital (CN)
- Henan Cancer Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-28
- DOI
- https://doi.org/10.3389/fimmu.2025.1504117
- Citations
- 2
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.04